June 24, 2026 02:32 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
No Hindi, no NEET: Vijay reignites Tamil Nadu's biggest political flashpoints | Messi creates World Cup history with record-breaking double; Mbappe equals Klose's mark hours later | Tech giant Oracle slashes 21,000 jobs while betting big on AI | 'Italy and I never beg': Meloni fires back at Trump over G7 photo claim | No more 'brother': Stalin's formal birthday greeting to Rahul reflects deepening rift | TMC seeks disqualification of 20 rebel MPs, Abhishek says 'membership should go' | Nara Lokesh pitches Andhra Pradesh as investment hub during Kolkata visit, sets $2.4 trillion economy goal | 'Least restrictive option': Setback for Telegram as Delhi HC backs Centre's ban ahead of NEET-UG re-test | Fortuner torched, BJP leaders burnt alive: Sand mining feud ends in triple murder in Chhattisgarh | 'If Modi is the leader and India is attacked, we'll be there': Trump's strong assurance at G7
Cervical Cancer Vax
Image Credit: Wallpaper Cave

India's first indigenously developed cervical cancer vaccine launched

| @indiablooms | Sep 02, 2022, at 06:47 am

The Serum Institute of India (SII) and the Department of Biotechnology (DBT) Thursday officially announced India's first indigenous vaccine for cervical cancer.

Union Minister of Science and Technology Jitendra Singh along with SII CEO Adar Poonawalla launched the vaccine at IIC Delhi.

Drugs Controller General of India (DCGI) granted market authorisation for the jibe in July.

As many as 42 lakh women have died due to this disease in India since 2019, according to World Health Organisation (WHO) data. It is the second most frequent cancer among women in the age group between 15 to 44.

The HPV vaccine protects against the types of HPV that most often cause cervical, vaginal, and vulvar cancers.

The vaccine may be priced between Rs 200-400 but it's not finalised yet, SII CEO, Adar Poonawalla said. The company plans to manufacture 200 million doses in 2 years.

The government may launch the vaccine under the National Immunisation programme for 9-14-year-old girls in the next few months.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.